• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market For Pain Management Drugs And Devices: Applications And Top Products

$3,500.00 – $7,000.00

Clear
SKU: KLI1006005 Categories: Drug Delivery Market Reports, Pharmaceuticals Market Research Pages: 250
  • Description
  • Table of Contents
  • Latest reports

Description

The market for pain management products is growing at a brisk pace, with some segments moving ahead at over 20%. The future for specialized pharmaceutical and medical device products in this market is bright and new opportunities exist for emerging treatment modalities as well.

The report presents the most up-to-date information about the top-producing pain management products in terms of revenues, and analyzes the market by specific pain sites as well. The report concentrates on the following application areas:

  • Burn Pain
  • Cancer Pain
  • Dental/Facial Pain
  • Headache Pain
  • MusculoSkeletal Pain
  • Neuropathic Pain
  • Pediatric Pain
  • Surgical and Trauma Pain
  • Other Pain

Market sizes are provided in U.S. dollars for the years 2003-2008 at the manufacturer’s level. Competitive market share of the top players is discussed in each application area, and individual product revenue breakdowns are provided for top products.

In addition to drugs, medical device markets and alternate pain management modalities are also included in the analysis. Medical devices included in the analysis include:

  • Transcutaneous Electrical Nerve Stimulators
  • Neuromuscular Stimulators
  • Spinal Cord Stimulators
  • PCA and Supplies
  • Electrothermal and Electromagnetic Therapy

Markets are discussed on two geographic levels. The focus of the analysis is global, but a break out of the U.S. market is provided as well. Trends in clinical practice, guidelines and protocols, reimbursement, regulatory affairs, and the competitive marketplace are also discussed.

Table of Contents

Chapter One: Executive Summary

Introduction

Scope and Methodology

Size and Growth of the Market

Issues and Trends

Leading Competitors

Chapter Two: Introduction and Overview

Definition of Pain

Magnitude of Pain

Physiology of Pain

Transduction

Transmission

Pain Pathways

Types of Pain

Measurement of Pain

Treatment Modalities—Pharmacologic Management

Analgesic Ladder

Recommended Drug and Route

Treatment Modalities—

Non-pharmacologic Management

Cognitive-Behavioral Therapies

Multidisciplinary Pain Management

Demographics

Chapter Three: Treatment Markets and Forecasts

Burn Pain

Overview of Top Products

Market Size and Growth

The U.S. Market

Non-U.S. Market

 

Cancer Pain

Breakthrough Cancer Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Dental/Facial Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Migraine Headache Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Musculoskeletal Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Neuropathic Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Obstetrical Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Pediatric Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

Surgical and Trauma Pain

Overview of Top Products

Market Size and Growth

U.S. Market

Non-U.S. Market

 

Chapter Four: Drug Delivery

Oral Drug Delivery

Parenteral Drug Delivery

Transdermal

Patient Controlled Analgesia

Intrathecal Implants

Electrotransport Drug Delivery

Drug Delivery in Development

Chapter Five: Pain Management Devices

Transcutaneous Electrical Nerve Stimulators

Neuromuscular Stimulators

Spinal Cord Stimulators and  Peripheral Nerve Stimulators

PCAs and Intrathecal Pain Pumps

Other Miscellaneous devices

Cranial electrotherapy stimulation

Electrothermal and Electromagnetic Therapy

Market Size and Growth

U.S. Market

Non-U.S. Market

Chapter Six: Alternate Treatment Modalities

Acupuncture

ETPS Neuropathic Acupuncture

Low Level Laser Light Therapy

Biofeedback

Relaxation

Acupressure

Massage Therapy

Natural Supplements in Pain Management

 

Chapter Seven: Issues and Trends

Overview

Regulatory issues

National Pain Care Policy Act of 2003

Barriers to Cancer Pain Management

Education

Managed Care Pain Management

The Fifth Vital Sign

Use of Psychopharmacology in Chronic Pain

Vioxx Recall

Increasing use of Botulinum Neurotoxin

Research and Development

The Elderly

Oxycontin Issues

Chapter Eight: Market Summary

Total Market Size and Forecast

Top Revenue-Producing Products

Competitive Analysis

Chapter Nine: Corporate Profiles

AAI Pharma Inc.

Abbott Laboratories

AstraZeneca plc.

Baxter International, Inc

Bristol-Myers Squibb Company

Cephalon Inc.

Compex Technologies

Empi, Inc

Encore Medical corporation

Endo Pharmaceutical Holdings Inc

GlaxoSmithKline plc

Johnson & Johnson, Inc.

Labopharm Inc.

Meditech International, Inc.

Medtronic, Inc.

Merck & Company

Novartis

Ortho-McNeil

Pfizer, Inc.

Purdue Pharma

Sanofi-Synthelabo (Sanofi-Aventis)

TEVA Pharmaceutical Industries, Ltd.

Watson Pharmaceuticals, Inc.

Wyeth

APPENDIX a: Company Directory

Appendix B: Selected Pain Management Organizations

List of Exhibits

Chapter One: Executive Summary

Table 1-1: World Pain Management Market 2003-2009

Table 1-2: World Pain Management Market by Product Segment

(Pain Type),  2003-2009

Chapter Two: Introduction and Overview

Table 2-1: Most Commonly Used Pain Quality Descriptors

Table 2-2: Pharmacokinetics of Step I Analgesics by Product

Table 2-3: Step II Analgesics: Pharmacokinetics

Table 2-4: Step III Analgesics: Pharmacokinetics

Table 2-5: Prevalence of Selected Pain-Related Conditions

Chapter three: Treatment Markets and Forecasts

Table 3-1: World Market for Burn Pain Market 2003-2009

Figure 3-1: World Market for Burn Pain Management 2003-2009

Table 3-2: U.S. Market for Burn Pain Management 2003-2009

Figure 3-2: U.S. Market for Burn Pain Management 2003-200

Table 3-3: Non-U.S. Market for Burn Pain Management 2003-2009

Figure 3-3: Non-U.S. Market for Burn Pain Management 2003-2009

Table 3-4: World Market for Cancer Pain Management 2003-2009

Figure 3-4: World Market for Cancer Pain Management 2003-2009

Table 3-5: The U.S. Market for Cancer Pain Management 2003-2009

Figure 3-5: The U.S. Market for Cancer Pain Management 2003-2009

Table 3-6: The Non-U.S. Market for Cancer Pain Management 2003-2009

Figure 3-6: The Non-U.S. Market for Cancer Pain Management 2003-2009

Table 3-7: The World Market for Dental/Facial Pain Management 2003-2009

Figure 3-7: The World Market for Dental/Facial Pain Management 2003-2009

Table 3-8: The U.S. Market for Dental/Facial Pain Management 2003-2009

Figure  3-8: The U.S. Market for Dental/Facial Pain Management 2003-2009

Table 3-9: The Non-U.S. Market for Dental/Facial Pain

Management 2003-2009

Figure 3-9: The Non-U.S. Market for Dental/Facial Pain

Management 2003-2009

Table 3-10: World Market for Migraine Pain Management 2003-2009

Figure 3-10: World Market for Migraine Pain Management 2003-2009

Table 3-11: The U.S. Market for Migraine Pain Management 2003-2009

Figure 3-11: The U.S. Market for Migraine Pain Management 2003-2009

Table 3-12: The Non-U.S. Market for Migraine Pain Management 2003-2009

Figure 3-12: The Non-U.S. Market for Migraine Pain Management 2003-2009

Table 3-13: World Market for Musculoskeletal Pain Management 2003-2009

Figure 3-13: World Market for Musculoskeletal Pain Management 2003-2009

Table 3-14: The U.S. Market for Musculoskeletal Pain Management 2003-2009

Figure 3-14: The U.S. Market for Musculoskeletal Pain Management 2003-2009

Table 3-15: The Non-U.S. Market for Musculoskeletal Pain

Management 2003-2009

Figure 3-15: The Non-U.S. Market for Musculoskeletal Pain

Management 2003-2009

Table 3-16: World Market for Neuropathic Pain Management 2003-2009

Figure 3-16: World Market for Neuropathic Pain Management 2003-2009

Table 3-17: The U.S. Market for Neuropathic Pain Management 2003-2009

Figure 3-17: The U.S. Market for Neuropathic Pain Management 2003-2009

Table 3-18: The Non-U.S. Market for Neuropathic Pain

Management 2003-2009

Figure 3-18: The Non-U.S. Market for Neuropathic Pain

Management 2003-2009

Table 3-19: World Market for Obstetrical Pain Management 2003-2009

Figure 3-19: World Market for Obstetrical Pain Management 2003-2009

Table 3-20: The U.S. Market for Obstetrical Pain Management 2003-2009

Figure 3-20: The U.S. Market for Obstetrical Pain Management 2003-2009

Table 3-21: The Non-U.S. Market for Obstetrical Pain Management 2003-2009

Figure 3-21: The Non-U.S. Market for Obstetrical Pain Management 2003-2009

Table 3-22: The World Market for Pediatric Pain Management 2003-2009

Figure 3-22: Total World Pediatric Pain Market 2003-2009

Table 3-23: The U.S. Market for Pediatric Pain Management 2003-2009

Table 3-23: The U.S. Market for Pediatric Pain Management 2003-2009

Table 3-24: The Non-U.S. Market for Pediatric Pain Management 2003-2009

Figure 3-24: The Non-U.S. Market for Pediatric Pain Management 2003-2009

Table 3-25: World Market for Surgical and Trauma Pain

Management 2003-2009

Figure 3-25: orld Market for Surgical and Trauma Pain

Management 2003-2009

Table 3-26: The U.S. Market for Surgical and Trauma Pain

Management 2003-2009

Figure 3-26: The U.S. Market for Surgical and Trauma Pain

Management 2003-2009

Table 3-27: The Non-U.S. Market for Surgical and Trauma Pain

Management 2003-2009

Figure 3-27: The Non-U.S. Market for Surgical and Trauma Pain

Management 2003-2009

Chapter Five: Pain Management Devices

Table 5-1: World Market for Pain Management Devices  2003-2009

Figure 5-1: World Market for Pain Management Devices  2003-2009

Table 5-2: U.S. Market for Pain Management Devices 2003-2009

Figure 5-2: U.S. Market for Pain Management Devices 2003-2009

Table 5-3: The Non-U.S. Market for Pain Management Devices 2003-2009

Figure 5-3: The Non-U.S. Market for Pain Management Devices 2003-2009

Chapter Six: Alternate Treatment Modalities

Table 6-1: Pain Management Supplements in Clinical Trials

Chapter Seven: Issues and Trends

Table 7-1: Pain Management Products in Development 2004

Chapter Eight: Market Summary

Table 8-1: World Pain Management Market 2003-2009

Table 8-2: World Pain Management Market by Product Segment (Pain Type + Devices)  2003-2009

Figure 8-1: World Pain Management Market by Product Segment 2003-2009

Figure 8-2: World Market Pain Management Market Share by Product Segment 2004

Figure 8-3: The World Market Pain Management  Projected Market Share by Product Segment 2009

Table 8-3: Revenues and Market Share by Top Revenue Producing Products 2004

Figure 8-4: Market Share by Top Revenue Producing Products 2004

Table 8-4: World Market for Top Pain Management Drugs Revenues and Major Segments of Participation by Competitor 2004

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures,...U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey,...
Scroll to top